Online Intervention to Modify Interpretation Biases in Depression

April 29, 2022 updated by: Universidad Complutense de Madrid

Brief Online Intervention to Modify Interpretation Biases in Depression: An Experimental Approach

Cognitive biases have been found to be possible causal and vulnerability factors for depression. There is empirical evidence on the presence of negative emotional biases in interpretation in people with depressive symptoms. A whole new area of research, called Cognitive Bias Modification (CBM), is focused on targeting negative cognitive emotional biases to investigate its impact on clinical symptoms. A recent meta-analysis has shown that this type of programs are effective in reducing cognitive biases but there is still controversy on their clinical value to reduce symptoms. The purpose of the study is to create a brief online intervention aimed to reduce negative emotional cognitive biases present in depression and to analyze its impact on clinical symptoms and well-being.

Study Overview

Detailed Description

More specifically, the intervention is framed within the area of CBM but it is rooted on techniques and change procedures used in cognitive-behavioral therapies. While original CBM studies train participants to change cognitive biases in an automatic manner, by forcing individuals to find positive outcomes to ambiguous scenarios, this new intervention focuses on teaching participants the meaning of emotional cognitive biases and how to modify them by using an effortful type of processing (i.e., looking for adaptive alternative interpretations to ambiguous stories).

The study has been design to overcome some of the limitations that have been pointed out in this emerging research area. Firstly, although there are recent efforts to understand how interpretation, attention and memory cognitive biases may be related, it is still not clear how they interact with each other. For this purpose, some authors have pointed out the need to use longitudinal data to see how one process may affect each other over time. Secondly, different systematic reviews and meta-analyses have investigated the moderating role of variables that may be affecting the heterogeneity of results found in CBM interventions. Mental imagery has been found to be a useful tool to help participants in their changing process, while there is no preferred number of sessions for these interventions. This study will help shed some light into this factors by using mental imagery during four sessions online.

Study Type

Interventional

Enrollment (Actual)

121

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28223
        • Faculty of Psychology, Complutense University of Madrid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Present (PHQ-9) or past (DID) episode of depression.
  • Access to Internet
  • Fluent in Spanish language

Exclusion Criteria:

  • Being under any psychological treatment
  • Having a psychotic condition
  • Having any cognitive impairment or condition that do not allow to follow the program
  • Serious auditory or visual impairments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
The experimental group will be exposed to a brief online program aimed at the modification of negative emotional cognitive biases. The program consists of an introduction and four 1-hour sessions, in video format. In each session, participants are required to complete some open questions and scales about the type of cognitive bias addressed in each session. All sessions are structured in four parts: 1) description and examples of some specific cognitive biases; 2) information about negative consequences of each bias; 3) explanation of adaptive strategies to modify cognitive biases (i.e., the four-questions approach used in standard Cognitive behavioral therapy); and 4) use of some practices to familiarize participants with the use of those strategies.
Brief online program aimed at the modification of negative interpretation biases.
Other Names:
  • Cognitive bias modification
  • Online cognitive bias intervention
  • Online interpretation bias intervention
Other: Waiting list group
The control group will be composed of individuals waiting for the treatment. Participants will not be exposed to the experimental program or any other between the pre-evaluation and the post-evaluation sessions. Participants in this group will have access to the potential benefits of the intervention after the post-evaluation of both groups.
Waiting list procedure for the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total score of pleasantness ratings given to the ambiguous scenarios presented in the Ambiguous Scenarios Test for Depression-II, (AST-D-II) to measure interpretation bias.
Time Frame: Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention) and the follow-up assessments (2 weeks and 3 months after completing the intervention).
Participants are asked to rate how pleasant they perceive 15 ambiguous scenarios in a scale from -5 (very unpleasant) to 5 (very pleasant).
Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention) and the follow-up assessments (2 weeks and 3 months after completing the intervention).
Total score of each of the three subscales of the Depression, Anxiety and Stress Scale-21 (DASS) questionnaire.
Time Frame: Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention) and the follow-up assessments (2 weeks and 3 months after completing the intervention).
Three subscales, with 7 items each, measuring symptoms of depression, anxiety and stress. Scores multiplied by 2 and summed up for each scale.
Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention) and the follow-up assessments (2 weeks and 3 months after completing the intervention).
Total score on general, eudaimonic, hedonic, and social well-being as measured by the Pemberton Happiness Index (PHI)
Time Frame: Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention) and the follow-up assessments (2 weeks and 3 months after completing the intervention).
Scale of 11 items measuring emotional well-being at different levels.
Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention) and the follow-up assessments (2 weeks and 3 months after completing the intervention).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ratio of the number of negative unscrambled sentences by the number of emotional unscrambled sentences in the Scrambled Sentence Test (SST) with cognitive load.
Time Frame: Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
The task presents 20 scrambled sentences with 6 words each. Participants are asked to construct a sentence using 5 of the 6 words. In addition, participants are shown a number, at the beginning of the task, to report it at the end (cognitive load). The resulting ratio of correctly negative unscrambled sentences between correctly emotional unscrambled sentences is an index of automatic interpretation bias.
Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
Proportion of time fixating the mouse cursor on negative over positive words to uncover them during the SST.
Time Frame: Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
During the SST, words are covered so that participants can only see them when placing the mouse cursor over them. The time spent on negative words is a measure of negative attention bias.
Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
Ratio of recalled negative unscrambled sentences and recalled emotional unscrambled sentences during the SST.
Time Frame: Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
Participants are asked to remember, during 5 minutes, the sentences they construct during the SST. The ratio of negative and emotional unscrambled sentences that participants recall is a measure of memory bias.
Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
Number of items viewed before reaching a decision in the Computerized Beads Task.
Time Frame: Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
The task presents two jars with beads containing positive or negative adjectives. Each jar has a different ratio of positive and negative words. Participants are told that one of the jars is going to be selected and one bead is going to be taken out and returned to it in each trial. Participants have to decide which jar is being used based on the number of positive and negative adjectives that are taken in each trial. The number of beads viewed before reaching a decision is an index of jumping to conclusion bias.
Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
Total score on the Dysfunctional Attitudes Scale (DAS)
Time Frame: Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
Scale of 40 sentences which participants have to rate from 1 (totally agree) to 7 (totally disagree). The sum of the scores given to each sentence is an index of dysfunctional cognitive schemas.
Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
Total score on the Brooding subscale of the Ruminative Responses Scale (RRS)
Time Frame: Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).
Subscale of 5 items which participants have to rate from 1 (totally disagree) to 5 (totally agree). The total score, ranging from 5 to 25, is an index of brooding.
Change from the first assesment (the day before starting the intervention) to the second assessment (the day after completing the intervention).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Four of more depressive symptoms (including anhedonia and depressed modd) in the Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Screening measure used after potential participants contact the main researcher to collaborate and before selecting participants to include in the study.
9 items measuring symptoms of depression from 1 (not at all) to 4 (nearly everyday). Diagnosis is made if participants select 3 o 4 in four or more items (including anhedonia and depressed mood).
Screening measure used after potential participants contact the main researcher to collaborate and before selecting participants to include in the study.
Five of more depressive symptoms (including anhedonia and depressed modd) in the Diagnostic Inventory of Depression (DID).
Time Frame: Screening measure used after potential participants contact the main researcher to collaborate and before selecting participants to include in the study.
Scale of 42 items measuring symptoms of depression in the past from 0 to 4.
Screening measure used after potential participants contact the main researcher to collaborate and before selecting participants to include in the study.
Total score in each of the 5 subscales of the EVEA assessment of current mood.
Time Frame: Participants self-administer the scale right before each session at home and right after completing each session.
Participants have to rate, from 0 to 10, their current level of anger, happiness, anxiety, depression, and boredom. Scores of each subscale (4 items each) are summed up.
Participants self-administer the scale right before each session at home and right after completing each session.
Total number of events, total number of times, mean score on negative impact and mean duration time of the negative impact of the negative events selected in the Stressful events questionnaire (based on Life Events Scale, LES).
Time Frame: The questionnaire is used 2 weeks and 3 moths after finishing the program (follow-ups).
A 47-item questionnaire in which participants select negative events they have experienced during the last two weeks or three months, the number of times each event was experienced, the emotional impact of the event and the duration time of the emotional impact. The different indexes represent experience of stressful events.
The questionnaire is used 2 weeks and 3 moths after finishing the program (follow-ups).
Total score on each of the two subscales (treatment expectancy and rationale credibility) of the Credibility and expectancy questionnaire (CEQ)
Time Frame: This scale is administered the day before starting the intervention.
6 items measuring patients' expectancy of treatment success and credibility of the treatment prior to the intervention.
This scale is administered the day before starting the intervention.
Total score on the Client Satisfaction Questionnaire (CSQ-8)
Time Frame: The measure is administered one day after finishing the intervention.
8 items measuring participants' satisfaction with the treatment rated with a 4-point scale where 1 reflects 'very low satisfaction' and 4 reflects 'very high satisfaction'.
The measure is administered one day after finishing the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Carmelo Vázquez, PhD, Universidad Complutense de Madrid

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2019

Primary Completion (Actual)

December 30, 2020

Study Completion (Actual)

March 1, 2021

Study Registration Dates

First Submitted

June 7, 2019

First Submitted That Met QC Criteria

June 11, 2019

First Posted (Actual)

June 17, 2019

Study Record Updates

Last Update Posted (Actual)

May 2, 2022

Last Update Submitted That Met QC Criteria

April 29, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

The authors have not decided yet on IPD sharing.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Interpretation bias modification program

Subscribe